Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors

被引:24
|
作者
Dong, Jinyun [1 ,2 ,4 ]
Huang, Guang [1 ]
Cui, Qing [1 ]
Meng, Qingqing [1 ]
Li, Shaoshun [1 ]
Cui, Jiahua [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai, Peoples R China
[2] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, 800 Dongchuan Rd, Shanghai, Peoples R China
[4] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP1; enzymes; CYP1B1; inhibitors; alpha-Naphthoflavone derivatives; SARs; DNA ADDUCT FORMATION; DESIGN; RESISTANCE; EXPRESSION; ANALOGS;
D O I
10.1016/j.ejmech.2020.112895
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 1B1 (CYP1B1) has been well validated as an attractive target for cancer prevention and drug resistance reversal. In continuation of our interest in this area, herein, a set of forty-six 6,7,10-trimethoxy-alpha-naphthoflavone derivatives varying in B ring was synthesized and screened against CYP1 enzymes, leading to the identification of fluorine-containing compound 15i as the most potent and selective CYP1B1 inhibitor (IC50 value of 0.07 nM), being 84-fold more potent than that of the template molecule ANF. Alternatively, the amino-substituted derivative 13h not only possessed a potent inhibitory effect on CYP1B1 (IC50 value of 0.98 nM), but also had a substantially increased water solubility as compared with the lead ANF (311 mu g/mL for 13h and <5 mu g/mL for ANF). The current study expanded the structural diversity of CYP1B1 inhibitors, and compound 13h could be considered as a promising starting point with great potential for further studies. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic?2B Antagonist
    Meibom, Daniel
    Meyer, Jutta
    von Buehler, Clemens-Jeremias
    Collins, Karl D.
    Maassen, Stefanie
    Gericke, Kersten Matthias
    Huser, Jorg
    Mittendorf, Joachim
    Hernandez, Nuria Ortega
    Schamberger, Jens
    Stampfuss, Jan
    Straub, Alexander
    Torge, Afra
    Witowski, Norbert
    Wunder, Frank
    JOURNAL OF MEDICINAL CHEMISTRY, 2023,
  • [22] BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic ?2B Antagonist
    Meibom, Daniel
    Meyer, Jutta
    von Buehler, Clemens-Jeremias
    Collins, Karl D.
    Maassen, Stefanie
    Gericke, Kersten Matthias
    Hueser, Joerg
    Mittendorf, Joachim
    Hernandez, Nuria Ortega
    Schamberger, Jens
    Stampfuss, Jan
    Straub, Alexander
    Torge, Afra
    Witowski, Norbert
    Wunder, Frank
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 4659 - 4670
  • [23] Discovery of a benzimidazole series as the first highly potent and selective ACSL1 inhibitors
    Hayashi, Kyohei
    Kondo, Noriyasu
    Omori, Naoki
    Yoshimoto, Ryo
    Hato, Megumi
    Shigaki, Shuhei
    Nagasawa, Ayumi
    Ito, Mana
    Okuno, Takayuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 33
  • [24] Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer
    Wang, Yazhou
    Wang, Chao
    Liu, Tingting
    Qi, Hongyun
    Chen, Shan
    Cai, Xin
    Zhang, Man
    Aliper, Alex
    Ren, Feng
    Ding, Xiao
    Zhavoronkov, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 67 (01) : 420 - 432
  • [25] Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases
    Wang, Tao
    Block, Michael A.
    Cowen, Scott
    Davies, Audrey M.
    Devereaux, Erik
    Gingipalli, Lakshmaiah
    Johannes, Jeffrey
    Larsen, Nicholas A.
    Su, Qibin
    Tucker, Julie A.
    Whitston, David
    Wu, Jiaquan
    Zhang, Hai-Jun
    Zinda, Michael
    Chuaqui, Claudio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) : 2063 - 2069
  • [26] Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1
    Raju, Baddipadige
    Verma, Himanshu
    Narendra, Gera
    Sapra, Bharti
    Silakari, Om
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (17): : 7975 - 7990
  • [27] Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B
    Taing, M
    Keng, YF
    Shen, K
    Wu, L
    Lawrence, DS
    Zhang, ZY
    BIOCHEMISTRY, 1999, 38 (12) : 3793 - 3803
  • [28] CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance (vol 131, pg 177, 2019)
    Sonawane, Vinay R.
    Siddique, Mohd Usman Mohd
    Gatchie, Linda
    Williams, Ibidapo S.
    Bharate, Sandip B.
    Jayaprakash, Venkatesan
    Sinha, Barij N.
    Chaudhuri, Bhabatosh
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 136
  • [29] Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors
    Xie, Fangzhou
    Liang, Yaoyao
    Xia, Yu
    Luo, Shuhua
    Jiang, Faqin
    Fu, Lei
    BIOORGANIC CHEMISTRY, 2019, 92
  • [30] Cushing's Syndrome: Development of Highly Potent and Selective CYP11B1 Inhibitors of the (Pyridylmethyl)pyridine Type
    Emmerich, Juliette
    Hu, Qingzhong
    Hanke, Nina
    Hartmann, Rolf W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (15) : 6022 - 6032